PharmiWeb3h
Contrast Media Market to Expand at 5-6% CAGR by 2029 | Growing Healthcare Investments and Technological Innovations
The Contrast Media Market is projected to grow at a CAGR of 5-6%. Key factors influencing the contrast media market include ...
Daiichi Sankyo, AstraZeneca’s Enhertu approved in European Union
Daiichi Sankyo (DSNKY) and AstraZeneca’s Enhertu has been approved in the European Union as a monotherapy for the treatment of adult patients with unresectable or metastatic hor ...
Japanese Market Sharply Lower; Down 2.4%
Extending the sharp losses in the previous session, the Japanese market is sharply lower on Friday, following the broadly negative cues from Wall Street overnight. The Nikkei ...
pharmaphorum19h
Daiichi Sankyo’s pexidartinib is first FDA-approved drug for rare tumour
Daiichi Sankyo’s pexidartinib has become the first FDA-approved therapy for tenosynovial giant cell tumour (TGCT), a rare form of tumour affecting joints and tendons. TGCT – which is also ...
Healio10h
Experimental therapy for brain cancer gives ‘hope’; will be investigated in upcoming trial
An award-winning pathologist who devoted his life to melanoma research became the first person to receive a novel ...
Le Lézard12h
Aker Horizons ASA: Notice of Annual General Meeting
The annual general meeting of Aker Horizons ASA (the "Company") will be held on Wednesday, 30 April 2025 at 13:00 CEST as a virtual meeting. The proposed agenda includes election of members of the ...